Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

Kforce (KFRC.N)*

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date	Stock Price (US$)	Price Target (US$)	Rating
2022-03-25	73.17	-	No Rating
2023-05-31	57.59	62.00	Neutral
2023-08-02	60.68	64.00	Neutral
2023-10-12	59.93	65.00	Neutral
2023-10-31	61.04	63.00	Neutral
2024-01-21	66.58	68.00	Neutral
2024-02-07	67.00	70.00	Neutral
2024-05-02	65.03	66.00	Neutral
2024-10-22	53.97	58.00	Neutral
2024-10-31	57.79	60.00	Neutral
2025-02-05	53.80	57.00	Neutral
2025-04-23	44.61	47.00	Neutral
2025-04-29	36.59	40.00	Neutral

Disclosures

UBS Securities LLC makes a market in the securities and/or ADRs of this company.
UBS holds a long or short position of 0.5% or more of the listed shares of this company.

Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day. Issuers with an EQ Rating & Price Target Table are covered by UBS-IB Equity Research Analysts. Issuers without an EQ Rating & Price Target Table are not single stock covered.

* Issuers marked with an asterisk are covered by UBS-IB Equity Research Analysts. Issuers without an asterisk are not single stock covered.